Rekah Pharmaceutical Industry Ltd Cash Flow Conversion Efficiency
Rekah Pharmaceutical Industry Ltd cash flow conversion efficiency. Based on the latest financial reports, Rekah Pharmaceutical Industry Ltd (REKA) has a cash flow conversion efficiency ratio of 0.099x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA13.82 Million ≈ $37.04K USD) by net assets (ILA140.18 Million ≈ $375.83K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Rekah Pharmaceutical Industry Ltd (2004–2025)
Cash flow conversion efficiency of Rekah Pharmaceutical Industry Ltd from 2004 to 2025. This chart illustrates how Rekah Pharmaceutical Industry Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Rekah Pharmaceutical Industry Ltd stock price today for real-time trading data and today's change.
Rekah Pharmaceutical Industry Ltd Cash Flow Conversion Ratio Explained
Rekah Pharmaceutical Industry Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Rekah Pharmaceutical Industry Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rekah Pharmaceutical Industry Ltd ranked by their cash flow conversion efficiency. Also see Rekah Pharmaceutical Industry Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fridenson
TA:FRDN
|
-0.054x |
|
TINYBUILD REGSCAT3 DL-001
F:8Z3
|
N/A |
|
K Way Information
TWO:5201
|
-0.031x |
|
Gencurix Inc
KQ:229000
|
0.023x |
|
Dong A Eltek Co. Ltd
KQ:088130
|
0.145x |
|
Radana Bhaskara Finance Tbk
JK:HDFA
|
-0.240x |
|
Enapter AG
F:H2O
|
-0.140x |
|
Globrands Group Ltd
TA:GLRS
|
0.902x |
Annual Cash Flow Conversion Efficiency for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of Rekah Pharmaceutical Industry Ltd from 2004 to 2025. Review Rekah Pharmaceutical Industry Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA144.21 Million ≈ $386.62K |
ILA12.95 Million ≈ $34.72K |
0.090x | -45.20% |
| 2024-12-31 | ILA161.98 Million ≈ $434.25K |
ILA26.54 Million ≈ $71.16K |
0.164x | -10.07% |
| 2023-12-31 | ILA155.59 Million ≈ $417.12K |
ILA28.35 Million ≈ $76.01K |
0.182x | -24.28% |
| 2022-12-31 | ILA162.08 Million ≈ $434.53K |
ILA39.00 Million ≈ $104.56K |
0.241x | +96.73% |
| 2021-12-31 | ILA173.06 Million ≈ $463.98K |
ILA21.17 Million ≈ $56.75K |
0.122x | +79.52% |
| 2020-12-31 | ILA165.59 Million ≈ $443.94K |
ILA11.28 Million ≈ $30.25K |
0.068x | -68.81% |
| 2019-12-31 | ILA155.22 Million ≈ $416.13K |
ILA33.91 Million ≈ $90.92K |
0.218x | +90.45% |
| 2018-12-31 | ILA150.66 Million ≈ $403.91K |
ILA17.28 Million ≈ $46.34K |
0.115x | -30.28% |
| 2017-12-31 | ILA144.62 Million ≈ $387.73K |
ILA23.80 Million ≈ $63.80K |
0.165x | -23.69% |
| 2016-12-31 | ILA105.86 Million ≈ $283.81K |
ILA22.82 Million ≈ $61.19K |
0.216x | +359.22% |
| 2015-12-31 | ILA123.66 Million ≈ $331.52K |
ILA5.81 Million ≈ $15.57K |
0.047x | +172.04% |
| 2014-12-31 | ILA77.06 Million ≈ $206.59K |
ILA1.33 Million ≈ $3.57K |
0.017x | -88.28% |
| 2013-12-31 | ILA79.51 Million ≈ $213.17K |
ILA11.71 Million ≈ $31.38K |
0.147x | -26.12% |
| 2012-12-31 | ILA71.17 Million ≈ $190.79K |
ILA14.18 Million ≈ $38.02K |
0.199x | +88.75% |
| 2010-12-31 | ILA63.78 Million ≈ $171.00K |
ILA6.73 Million ≈ $18.05K |
0.106x | -73.98% |
| 2009-12-31 | ILA64.15 Million ≈ $171.99K |
ILA26.03 Million ≈ $69.78K |
0.406x | +261.86% |
| 2008-12-31 | ILA58.62 Million ≈ $157.17K |
ILA6.57 Million ≈ $17.62K |
0.112x | -39.57% |
| 2007-12-31 | ILA67.10 Million ≈ $179.88K |
ILA12.45 Million ≈ $33.38K |
0.186x | +155.46% |
| 2005-12-31 | ILA58.85 Million ≈ $157.77K |
ILA4.27 Million ≈ $11.46K |
0.073x | -80.15% |
| 2004-12-31 | ILA48.86 Million ≈ $131.00K |
ILA17.87 Million ≈ $47.92K |
0.366x | -- |
About Rekah Pharmaceutical Industry Ltd
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeut… Read more